Cerebral amyloid angiopathy and Alzheimer disease—one peptide, two pathways

SM Greenberg, BJ Bacskai… - Nature Reviews …, 2020‏ - nature.com
The shared role of amyloid-β (Aβ) deposition in cerebral amyloid angiopathy (CAA) and
Alzheimer disease (AD) is arguably the clearest instance of crosstalk between …

Animal models of neurodegenerative diseases

TM Dawson, TE Golde, C Lagier-Tourenne - Nature neuroscience, 2018‏ - nature.com
Animal models of adult-onset neurodegenerative diseases have enhanced the
understanding of the molecular pathogenesis of Alzheimer's disease, Parkinson's disease …

Current state of Alzheimer's fluid biomarkers

JL Molinuevo, S Ayton, R Batrla, MM Bednar… - Acta …, 2018‏ - Springer
Alzheimer's disease (AD) is a progressive neurodegenerative disease with a complex and
heterogeneous pathophysiology. The number of people living with AD is predicted to …

Amyloid-beta and tau protein beyond Alzheimer's disease

M Abyadeh, V Gupta, JA Paulo… - Neural Regeneration …, 2024‏ - journals.lww.com
The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to
play key roles in Alzheimer's disease pathogenesis and are considered the main …

The advent of Alzheimer treatments will change the trajectory of human aging

DJ Selkoe - Nature Aging, 2024‏ - nature.com
Slowing neurodegenerative disorders of late life has lagged behind progress on other
chronic diseases. But advances in two areas, biochemical pathology and human genetics …

Role of tau protein in Alzheimer's disease: The prime pathological player

S Muralidar, SV Ambi, S Sekaran, D Thirumalai… - International journal of …, 2020‏ - Elsevier
Alzheimer's disease (AD) is a prevalently found tauopathy characterized by memory loss
and cognitive insufficiency. AD is an age-related neurodegenerative disease with two major …

Rodent models for Alzheimer disease

J Götz, LG Bodea, M Goedert - Nature Reviews Neuroscience, 2018‏ - nature.com
Animal models are indispensable tools for Alzheimer disease (AD) research. Over the
course of more than two decades, an increasing number of complementary rodent models …

Molecular pathogenesis of Alzheimer's disease: an update

A Sanabria-Castro, I Alvarado-Echeverría… - Annals of …, 2017‏ - karger.com
Dementia is a chronic or progressive syndrome, characterized by impaired cognitive
capacity beyond what could be considered a consequence of normal aging. It affects the …

Amyloid-beta: a crucial factor in Alzheimer's disease

S Sadigh-Eteghad, B Sabermarouf, A Majdi… - Medical principles and …, 2015‏ - karger.com
Alzheimer's disease (AD) is the most prevalent form of dementia which affects people older
than 60 years of age. In AD, the dysregulation of the amyloid-beta (Aβ) level leads to the …

[HTML][HTML] Disease-modifying therapies for Alzheimer's disease: more questions than answers

TE Golde - Neurotherapeutics, 2022‏ - Elsevier
Scientific advances over the last four decades have steadily infused the Alzheimer's disease
(AD) field with great optimism that therapies targeting Aβ, amyloid, tau, and innate immune …